NYSE · Health Care

LABCORP HOLDINGS INC LH

Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C, PSA, tests for sexually transmitted diseases, vitamin D testing, microbiology cultures and procedures, and alcohol and other substance abuse tests.

Medical Specialities

Company profile

Business mix

  • It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services.
  • It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases.
  • In addition, the company offers digital pathology solutions, a pathology platforms that support the digitization, centralized review, and sharing of pathology slides.
  • It serves clients, third party, medicare/medicaid, patients, pharmaceutical, biotechnology, medical device, diagnostic companies, and CROs.

Current key questions

  • Can the company's products, services, or pipeline expand adoption within diagnostics & research?
  • How do reimbursement, regulation, clinical data, patents, and commercial execution affect growth?
  • Can margins and cash flow improve while funding research, manufacturing, or go-to-market investment?
Holders 3 Current sample portfolio
Public mentions 0 Videos / interviews / letters
Valuation snapshot
PE 23.49 FCF 6.37% Buyback 1.01%
2026-06-07

Current firm holders

Firm Weight Value Filing period
Ariel Investments John Rogers 1.1% $94.5M 2026-03-31
Gotham Asset Management Joel Greenblatt 0.1% $48.6M 2026-03-31
Weitz Investment Management Wallace Weitz 1.8% $26.4M 2026-03-31

Recent trading changes over the last 3 quarters

Net buyers 1 Last 3 13F filing periods
Net reducers 2 Last 3 13F filing periods
Unchanged holders 0 Share count unchanged
Increase amount $30.4M Estimated from net added shares
Reduction amount $14.3M Estimated from net reduced shares
Net share change / base shares +10.5% +60,434 / 574,851
Gotham Asset Management Joel Greenblatt 3 filing periods
13F 2025-09-30 Filed 2025-11-14
Major increase Shares 39.2% 13F value change +$9.4M
13F 2025-12-31 Filed 2026-02-17
Major increase Shares 70.1% 13F value change +$13.3M
13F 2026-03-31 Filed 2026-05-15
Minor increase Shares 12.7% 13F value change +$8.1M
Settlement As of 13F 2026-03-31 · Filed 2026-05-15
Base shares 68,278 Last 3 periods +113,938 (+166.9%) Total shares 182,216 Value $48.6M
Weitz Investment Management Wallace Weitz 3 filing periods
13F 2025-09-30 Filed 2025-11-10
Minor reduction Shares -1.0% 13F value change +$3.1M
13F 2025-12-31 Filed 2026-02-12
Major reduction Shares -28.6% 13F value change -$15.1M
13F 2026-03-31 Filed 2026-05-14
Minor reduction Shares -0.7% 13F value change +$1.4M
Settlement As of 13F 2026-03-31 · Filed 2026-05-14
Base shares 141,175 Last 3 periods -42,125 (-29.8%) Total shares 99,050 Value $26.4M
Ariel Investments John Rogers 3 filing periods
13F 2025-09-30 Filed 2025-11-14
Minor reduction Shares -0.7% 13F value change +$8.2M
13F 2025-12-31 Filed 2026-02-13
Minor reduction Shares -0.8% 13F value change -$13.8M
13F 2026-03-31 Filed 2026-05-14
Minor reduction Shares -1.7% 13F value change +$4.1M
Settlement As of 13F 2026-03-31 · Filed 2026-05-14
Base shares 365,398 Last 3 periods -11,379 (-3.1%) Total shares 354,019 Value $94.5M

Recent mentions

No public mentions.